Edward C. Taylor

For other people named Ted Taylor, see Ted Taylor (disambiguation).
For other people named Edward Taylor, see Edward Taylor (disambiguation).

Edward Curtis Taylor, Jr. (born August 3, 1923)[1]) is an American chemist who designed and synthesized the chemotherapy drug pemetrexed (brand name Alimta), an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain. As of 2009, royalties for this drug from Eli Lilly & Co. paid to Princeton University were sufficient to completely finance a state-of-the-art 263,000-square-foot (24,400 m2) chemistry laboratory building.[2]

In 2006 Taylor was named a Hero of Chemistry by the American Chemical Society. Taylor has completed 187 PhD students.

References

  1. ↑ "Edward C. Taylor, Ph.D.: Curriculum Vitae". Princeton University. Retrieved 2009-04-11.
  2. ↑ Shirley M. Tilghman (April 1, 2009). "It all began with butterflies". Princeton Alumni Weekly. 109 (11): 2.
This article is issued from Wikipedia - version of the 4/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.